Beat M Jucker Selected Research

N- (3- (1- methylethyl)- 3- ((3- (trifluoromethyl)- 7,8- dihydro- 1,6- naphthyridin- 6(5H)- yl)carbonyl)cyclopentyl)tetrahydro- 2H- pyran- 4- amine

2/2010

Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beat M Jucker Research Topics

Disease

9	Myocardial Infarction 01/2020 - 12/2004
8	Infarction (Infarctions) 10/2013 - 11/2003
6	Reperfusion Injury 01/2015 - 11/2003
5	Hypertrophy 01/2020 - 07/2007
5	Ischemia 01/2015 - 11/2003
4	Cardio-Renal Syndrome 01/2021 - 01/2017
4	Neoplasms (Cancer) 01/2019 - 03/2013
4	Atherosclerotic Plaque (Atheroma) 02/2015 - 04/2005
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 01/2011
4	Heart Failure 05/2013 - 07/2007
3	Fibrosis (Cirrhosis) 01/2020 - 04/2013
3	Cardiomegaly (Heart Hypertrophy) 01/2017 - 01/2012
3	Inflammation (Inflammations) 02/2015 - 02/2008
3	Insulin Resistance 02/2005 - 07/2002
2	Necrosis 05/2021 - 03/2019
2	Stroke (Strokes) 01/2012 - 12/2003
2	Hypertension (High Blood Pressure) 01/2012 - 12/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 06/2006
2	Abdominal Aortic Aneurysm 08/2009 - 11/2008
2	Dyslipidemias (Dyslipidemia) 05/2008 - 11/2003
1	Chronic Renal Insufficiency 05/2021
1	Left Ventricular Dysfunction 01/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019
1	Cysts 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2018
1	Chemical and Drug Induced Liver Injury 01/2018
1	Edema (Dropsy) 12/2017
1	Mesothelioma 06/2016
1	Acute Coronary Syndrome 10/2013
1	Body Weight (Weight, Body) 10/2013
1	Pulmonary Edema 11/2012
1	Ventricular Dysfunction 08/2010
1	Hypoxia (Hypoxemia) 08/2010
1	Aneurysm (Aneurysms) 08/2009

Drug/Important Bio-Agent (IBA)

5	MAP Kinase Kinase Kinase 5IBA 01/2021 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2019 - 10/2007
4	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2017 - 04/2005
3	CollagenIBA 01/2020 - 01/2017
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015 - 01/2011
3	Contrast MediaIBA 08/2009 - 04/2005
2	IndicanIBA 05/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2017
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2017 - 04/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 07/2002
2	SaltsIBA 01/2012 - 12/2003
2	PPAR deltaIBA 05/2008 - 07/2007
2	p38 Mitogen-Activated Protein KinasesIBA 02/2008 - 12/2003
2	Rosiglitazone (Avandia)FDA Link 02/2005 - 02/2003
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2021
1	Angiopoietin-2IBA 05/2021
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2020
1	InterleukinsIBA 03/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2019
1	Aquaporin 1IBA 01/2019
1	Proline (L-Proline)FDA Link 01/2017
1	GSK2849330IBA 01/2017
1	4-cresol sulfateIBA 01/2017
1	Uremic ToxinsIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2016
1	LigandsIBA 06/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2016
1	FP-1039IBA 06/2016
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 02/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Exenatide (Byetta)FDA Link 10/2013
1	Serum AlbuminIBA 10/2013
1	Therapeutic UsesIBA 10/2013
1	salicylhydroxamic acid (SHAM)IBA 05/2013
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2013
1	N- ((4- cyano- 2- (trifluoromethyl)phenyl)methyl)- 3- ((4- methyl- 6- (methylamino)- 1,3,5- triazin- 2- yl)amino)cyclohexanecarboxamideIBA 04/2013
1	N- ((4- bromo- 2- ((trifluoromethyl)oxy)phenyl)methyl)- 1- (4- methyl- 6- (methylamino)- 1,3,5- triazin- 2- yl)- 4- piperidinecarboxamideIBA 04/2013
1	Connective Tissue Growth FactorIBA 04/2013
1	GSK2656157IBA 03/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	thymosin beta(4)IBA 01/2013
1	GSK2193874IBA 11/2012
1	Soluble Guanylyl CyclaseIBA 01/2012
1	BAY 60-4552IBA 01/2012
1	rGLP-1 proteinIBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 08/2010
1	Oxygen (Dioxygen)IBA 08/2010
1	N- ((1- (cyclopropylethyl)- 6- fluoro- 4- hydroxy- 2- oxo- 1,2- dihydro- 3- quinolinyl)carbonyl)glycineIBA 08/2010
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 08/2010
1	CC ChemokinesIBA 02/2010
1	N- (3- (1- methylethyl)- 3- ((3- (trifluoromethyl)- 7,8- dihydro- 1,6- naphthyridin- 6(5H)- yl)carbonyl)cyclopentyl)tetrahydro- 2H- pyran- 4- amineIBA 02/2010

Therapy/Procedure

5	Therapeutics 01/2020 - 10/2007
2	Ligation 08/2010 - 02/2005
1	Nephrectomy 01/2020
1	Transplantation 01/2018
1	General Anesthesia 05/2013